Seiji Minota

5PUBLICATIONS
11CO-AUTHORS
Regenerative medicine (incl. stem cells)Respiratory diseasesAutoimmunityMedical biochemistry - proteins and peptides (incl. medical proteomics)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 21, 2024
Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission.

Eiji Sakashita, Katsuya Nagatani, Hitoshi Endo

|Jul 12, 2021
Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.

Kyoko Honne, Masashi Bando, Makiko Naka Mieno

|Sep 30, 2020
Risk factors correlated with immunosuppressant discontinuation in antineutrophil cytoplasmic antibody-associated vasculitis patients.

Takamasa Murosaki, Takeo Sato, Katsuya Nagatani

|Feb 22, 2019
Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis.

Takao Nagashima, Yasuyuki Kamata, Masahiro Iwamoto

|Dec 06, 2017
Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".

Yasuyuki Kamata, Seiji Minota

Pageof 1

Frequent Collaborators

2 joint publications

Yasuyuki Kamata

2 joint publications

Masahiro Iwamoto

1 joint publications

Takao Nagashima

1 joint publications

Hitoaki Okazaki